Cover Image
市場調查報告書

OTC藥品世界市場未來預測 (2017∼2027年):咳嗽、感冒、過敏藥、鎮痛劑、胃腸藥、皮膚藥、護眼用品、禁煙輔助產品

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

出版商 Visiongain Ltd 商品編碼 320889
出版日期 內容資訊 英文 177 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
OTC藥品世界市場未來預測 (2017∼2027年):咳嗽、感冒、過敏藥、鎮痛劑、胃腸藥、皮膚藥、護眼用品、禁煙輔助產品 Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others
出版日期: 2017年08月15日 內容資訊: 英文 177 Pages
簡介

世界OTC藥品 (一般用藥品) 市場、2016年億1270美元規模、預測今後將以6.5%CAGR (年複合成長率) 成長。市場的23%由咳嗽、感冒、過敏用藥品佔據。

本報告針對世界OTC藥品 (一般用) 市場分析、提供產品、市場概要與最新動向、市場規模動向預測 (今後11年)、產品分類、地區分類詳細動向、市場品質趨勢 (促進、阻礙因素、市場向心力)、主要企業檔案、今後市場成長可能性。

第1章 分析概要

第2章 OTC藥品概略

  • OTC藥品是什麼?
  • OTC藥品分類
  • OTC藥品條件
  • OTC轉換:處方藥轉為OTC的方法?
  • OTC藥品製造與流通
  • OTC藥品各國法規

第3章 世界OTC藥品市場預測 (今後11年)

  • OTC藥品市場現狀

第4章 世界OTC藥品市場:產品分類預測 (今後11年)

  • 概要
  • 咳嗽、感冒、過敏
    • 抗過敏產品
  • 鎮痛劑 (內服藥、外用藥)
  • 胃腸藥
  • 皮膚藥
    • 割傷、外傷
    • 青春痘
    • 發疹、發癢、皮膚炎/濕疹
    • 皮膚真菌感染症
    • 痔瘡
    • 其他
  • 護眼用品
    • 乾眼症候群
    • 細菌性結膜炎
    • 眼睛過敏/過敏性結膜炎
    • 眼睛過敏/過敏性結膜炎治療藥
  • 禁煙輔助產品
  • 其他

第5章 世界OTC藥品市場:地區分類、國家分類預測 (今後11年)

  • 地區分類市場預測 (今後11年間分)
  • 北美市場 (美國、加拿大、墨西哥)
  • 南美市場 (巴西、阿根廷、巴拉圭、玻利維亞)
  • 歐洲市場 (法國、德國、英國、西班牙、義大利ジ)
  • 亞太地區市場 (日本、印度、澳洲、泰國)
  • 其他國家市場 (RoW:中東、非洲)

第6章 OTC藥品市場品質分析

  • OTC藥品市場SWOT分析
  • 優點
    • 整體相關人士對OTC藥品轉移皆有好處
      • 藥品製造商:獲得OTC藥品銷售利益
      • 保險支付者:降低成本負擔
      • 醫療業者:成本轉移給患者
    • 許多製藥企業擁有廣泛的OTC藥品檔案
    • 規範單位獎勵OTC藥品
    • 零售藥局、替代流通方式發達、有效率的流通網絡
    • 控制偽造藥品消費
    • 文化變化、使用OTC藥品自我治療
  • 弱點
    • 製藥企業:持續關注處方藥
    • 製造問題:影響OTC藥品銷售、評價
    • OTC產品容易受政府價格規範影響
    • OTC藥品受到成本壓力
  • 機會
    • 人口、經濟構造變化創造成長機會
    • OTC轉換的最新分類
    • 新興國家市場急速成長
    • 最新醫療技術與OTC藥品認證的可能性
    • 社群媒體/線上行銷的販售機會
    • 自我治療降低疾病未治療率的可能性
  • 威脅
    • 私人品牌的競爭讓收益率下降
    • 安全性、誤用規範的不安感讓產品撤退
    • 特定國家、集團對OTC轉換的抵抗感
  • 五力分析
    • 企業競爭激烈度 (高)
    • 新加入企業威脅 (中)
    • 供應商交涉力 (低)
    • 買方交涉力 (中)
    • 代替產品威脅 (中)

第7章 OTC藥品市場代表企業

  • Bayer AG
    • 企業概要
    • 產品檔案
    • 近年動向
  • GlaxoSmithKline PLC (GSK Consumer Care)
  • Johnson & Johnson
  • Perrigo Company PLC
  • 第一三共
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A.
  • Reckitt Benckiser Group PLC
  • Cipla Inc.

第8章 結論

  • 世界OTC藥品市場未來展望
    • OTC藥品知名分類
    • 主要國家市場:新興國家佔大部分佔有率
    • 世界OTC藥品市場成長率
    • 今後OTC轉換的可能性
    • 潛在的OTC市場
  • 分析結論

附錄

圖表一覽

分析企業、機構一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0224

The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceutical market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 177-page report you will receive 82 tables and 79 figures - all unavailable elsewhere.

The 177-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global OTC Pharmaceutical Market forecasts from 2017-2027
  • This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
  • Analgesics
  • Cough, cold and allergy products
  • Dermatological products
  • Gastrointestinal products
  • Eye Care
  • Smoking Cessation Aids
  • Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

  • This report provides individual revenue forecasts to 2027 for these regional and national markets:
  • North America: the US, Canada, Mexico
  • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
  • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
  • Rest of the World: Middle East, Africa, Other Countries

image1

  • Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market
  • This report discusses the leading companies in the Global OTC Pharmaceutical market
  • Bayer AG
  • GlaxoSmithKline (GSK) Consumer Care
  • Perrigo Company PLC
  • Johnson & Johnson
  • Daiichi Sankyo Co., Ltd
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A
  • Reckitt Benckiser Group PLC
  • Cipla, Inc.

Visiongain's study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 The OTC Pharmaceuticals Market Overview
  • 1.2 Research Methodology
  • 1.3 Global OTC Pharmaceutical Market Segmentation
  • 1.4 Why You Should Read This Report
  • 1.5 How this report delivers?
  • 1.6 Key Questions Answered by This Analytical Report
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Who is This Report For?
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals

  • 2.1 What Are OTC Pharmaceuticals?
  • 2.2 Classification of OTC Pharmaceuticals
  • 2.3 What are the Requirements for an OTC Pharmaceutical Drug?
  • 2.4 OTC Switching
    • 2.4.1 How Is a Drug Switched from Prescription to OTC?
  • 2.5 Manufacturing and Distribution of OTC Pharmaceuticals
  • 2.6 Regulation of OTC Pharmaceuticals
    • 2.6.1 Regulation of OTC Pharmaceuticals in the US
    • 2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
    • 2.6.3 Regulation of OTC Pharmaceuticals in Europe
    • 2.6.4 Regulation of OTC Pharmaceuticals in China
    • 2.6.5 Regulation of OTC Pharmaceuticals in Others Countries

3. Global OTC Pharmaceutical Market Forecast 2017-2027

  • 3.1 The Current State of the OTC Pharmaceutical Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2017- 2027

  • 4.1 Overview
  • 4.2 Cough, Cold and Allergy
    • 4.2.1 Anti-Allergy Products
  • 4.3 Analgesics
    • 4.3.1 Internal Analgesics
    • 4.3.2 External Analgesics
  • 4.4 Gastrointestinal
  • 4.5 Dermatological
    • 4.5.1 Minor Cuts and Wounds
    • 4.5.2 Acne
    • 4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema
    • 4.5.4 Cold Sores
    • 4.5.5 Warts
    • 4.5.6 Fungal Skin Infections
    • 4.5.7 Haemorrhoids
    • 4.5.8 Other Dermatological Products
  • 4.6 Eye Care
    • 4.6.1 Dry Eye Syndrome
    • 4.6.2 Bacterial Conjunctivitis
    • 4.6.3 Ocular Allergy and Allergic Conjunctivitis
    • 4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
  • 4.7 Smoking Cessation Aids
  • 4.8 Other Products

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2017- 2027

  • 5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2017-2027
  • 5.2 North American OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.1 USA OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.2 Canada OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.3 Mexico OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.3 South American OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.1 Brazil OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.2 Argentina OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.3 Paraguay OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.4 Bolivia OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.5 Rest of South America OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.4 European OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.1 France OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.2 Germany OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.3 UK OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.4 Spain OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.5 Italy OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.6 Rest of Europe OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.5 Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.1 China OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.2 Japan OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.3 India OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.4 Australia OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.5 Thailand OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.6 Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.6 Rest of World OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.1 Middle East OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.2 Africa OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.3 Other Countries OTC Pharmaceutical Market Forecasts 2017-2027

6. Qualitative Analysis of the OTC Pharmaceutical Market, 2017-2027

  • 6.1 SWOT Analysis of the OTC Pharmaceutical Market
  • 6.2 Strengths
    • 6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
      • 6.2.1.1 Manufacturers Can Reap OTC Sales Benefits
      • 6.2.1.2 Third Party Payers: Reducing the Cost Burden
      • 6.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
    • 6.2.2 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio
    • 6.2.3 Regulators Are Encouraging OTC Approvals
    • 6.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
    • 6.2.5 Deterring the Consumption of Counterfeit Drugs
    • 6.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
  • 6.3 Weaknesses
    • 6.3.1 Pharma Companies Remain Focused on Prescription Drugs
    • 6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
    • 6.3.3 OTC Products are Vulnerable to Price Controls by Governments
    • 6.3.4 Downward Cost Pressures of OTC Drugs
  • 6.4 Opportunities
    • 6.4.1 Demographic and Economic Changes Will Create Growth Opportunities
    • 6.4.2 New OTC Switch Categories
    • 6.4.3 Strong Growth in Emerging Markets
    • 6.4.4 New Healthcare Technologies May enable OTC Approvals
    • 6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
    • 6.4.6 Self-Medication Can Reduce the Under Treatment of Disease
  • 6.5 Threats
    • 6.5.1 Competition from Private-Label Brands Will Reduce Profitability
    • 6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
    • 6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
  • 6.6 Porter's Five Forces Analysis of the OTC Pharmaceutical Market
    • 6.6.1 Rivalry Among Competitors [High]
    • 6.6.2 Threat of New Entrants [Medium]
    • 6.6.3 Power of Suppliers [Low]
    • 6.6.4 Power of Buyers [Medium]
    • 6.6.5 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceutical Market

  • 7.1 Bayer AG
    • 7.1.1 Bayer AG: Company Overview
    • 7.1.2 Bayer AG: Product Portfolio
    • 7.1.3 Bayer AG: Recent Developments
  • 7.2 GlaxoSmithKline PLC (GSK Consumer Care)
    • 7.2.1 GlaxoSmithKline PLC: Company Overview
    • 7.2.2 GlaxoSmithKline PLC: Product Portfolio
    • 7.2.3 GlaxoSmithKline PLC: Recent Developments
  • 7.3 Johnson & Johnson
    • 7.3.1 Johnson & Johnson: Company Overview
    • 7.3.2 Johnson & Johnson: Product Portfolio
    • 7.3.3 Johnson & Johnson: Recent Developments
  • 7.4 Perrigo Company PLC
    • 7.4.1 Perrigo Company PLC: Company Overview
    • 7.4.2 Perrigo Company PLC: Product Portfolio
    • 7.4.3 Perrigo Company PLC: Recent Developments
  • 7.5 Daiichi Sankyo Co., Ltd.
    • 7.5.1 Daiichi Sankyo Co., Ltd.: Company Overview
    • 7.5.2 Daiichi Sankyo Co., Ltd.: Recent Developments
  • 7.6 Pfizer Inc.
    • 7.6.1 Pfizer Inc.: Company Overview
    • 7.6.2 Pfizer Inc.: Product Portfolio
    • 7.6.3 Pfizer Inc.: Recent Developments
  • 7.7 Procter & Gamble
    • 7.7.1 Procter & Gamble: Company Overview
    • 7.7.2 Procter & Gamble: Product Portfolio
    • 7.7.3 Procter & Gamble: Recent Developments
  • 7.8 Sanofi S.A.
    • 7.8.1 Sanofi S.A.: Company Overview
    • 7.8.2 Sanofi S.A.: Product Portfolio
    • 7.8.3 Sanofi S.A: Recent Developments
  • 7.9 Reckitt Benckiser Group PLC
    • 7.9.1 Reckitt Benckiser Group PLC: Company Overview
    • 7.9.2 Reckitt Benckiser Group PLC: Product Portfolio
    • 7.9.3 Reckitt Benckiser Group PLC: Recent Developments
  • 7.10 Cipla Inc.
    • 7.10.1 Cipla Inc.: Company Overview
    • 7.10.2 Cipla Inc.: Product Portfolio
    • 7.10.3 Cipla Inc.: Recent Developments

8. Conclusions

  • 8.1 The World OTC Pharmaceutical Market in 2016-2017
    • 8.1.1 The Leading OTC Product Categories
    • 8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion
    • 8.1.3 The Global OTC Market Growth Factors
    • 8.1.4 Potential OTC Switching, 2017-2027
    • 8.1.5 Emerging OTC Markets
  • 8.2 Concluding Remarks

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.1 Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2017-2027
  • Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2017
  • Table 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.4 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2017-2027
  • Table 4.5 OTC Internal Analgesic Active Ingredients, 2017
  • Table 4.6 OTC External Analgesic Active Ingredients, 2017
  • Table 4.7 Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.8 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.9 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.10 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.11 OTC Antifungal Active Ingredients, 2017
  • Table 4.12 Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.13 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2017-2027
  • Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2017
  • Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2017
  • Table 4.16 OTC Ocular Allergy Active Ingredients, 2017
  • Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.18 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2017
  • Table 4.20 Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.21 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.22 Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.23 OTC Pharmaceutical Market for Other Products Market Forecast,by Geography ($bn, AGR%) 2017-2027
  • Table 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 5.2 North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.3 USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.6 South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.7 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.8 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.9 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.10 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.11 Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.12 European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.13 France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.14 Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.15 UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.16 Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.17 Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.18 Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.19 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.20 China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.21 Selected Leading Companies in the Japanese OTC Pharma Market, 2017
  • Table 5.22 Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.23 India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.24 Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.25 Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.26 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.27 Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.28 Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.29 Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.30 Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 7.1 Bayer AG: Company Overview
  • Table 7.2 Bayer AG: Product Portfolio
  • Table 7.4 GlaxoSmithKline PLC: Company Overview
  • Table 7.5 GlaxoSmithKline PLC: Product Portfolio
  • Table 7.6 GlaxoSmithKline PLC: Recent Developments
  • Table 7.7 Johnson & Johnson: Company Overview
  • Table 7.8 Johnson & Johnson: Product Portfolio
  • Table 7.9 Johnson & Johnson: Recent Developments
  • Table 7.10 Perrigo Company PLC: Company Overview
  • Table 7.11 Perrigo Company PLC: Product Portfolio
  • Table 7.12 Perrigo Company PLC: Recent Developments
  • Table7.13 Daiichi Sankyo Co., Ltd.: Company Overview
  • Table 7.14 Daiichi Sankyo Co., Ltd.: Recent Developments
  • Table 7.15 Pfizer Inc.: Company Overview
  • Table 7.16 Pfizer Inc.: Product Portfolio
  • Table 7.17 Pfizer Inc.: Recent Developments
  • Table 7.18 Procter & Gamble: Company Overview
  • Table 7.19 Procter & Gamble: Product Portfolio
  • Table 7.20 Procter & Gamble: Recent Developments
  • Table 7.21 Sanofi S.A.: Company Overview
  • Table 7.22 Sanofi S.A.: Product Portfolio
  • Table 7.23 Sanofi S.A: Recent Developments
  • Table 7.24 Reckitt Benckiser Group PLC: Company Overview
  • Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio
  • Table 7.26 Reckitt Benckiser Group PLC: Recent Developments
  • Table 7.27 Cipla Inc.: Company Overview
  • Table 7.28 Cipla Inc.: Product Portfolio
  • Table 7.29 Cipla Inc.: Recent Developments

List of Figures

  • Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets
  • Figure 2.1 The OTC Pharmaceutical Supply Chain, 2017
  • Figure 3.1 OTC Pharmaceutical Market, by Product, ($bn), 2017-2027
  • Figure 3.2 OTC Pharmaceutical Market, by Geography, ($bn), 2017-2027
  • Figure 4.1 OTC Pharmaceutical Market, by Product, Market Share (%), 2016
  • Figure 4.2 OTC Pharmaceutical Market, by Product, Forecast ($bn) 2017-2027
  • Figure 4.3 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.4 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2017-2027
  • Figure 4.5 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.6 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.7 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2017-2027
  • Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.9 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2017-2027
  • Figure 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn) 2017-2027
  • Figure 5.2 Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2016
  • Figure 5.3 North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.4 North America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.5 USA OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.6 Canada OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.7 Mexico OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.8 South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.9 South America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.10 Brazil OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.11 Argentina OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.12 Paraguay OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.13 Bolivia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.14 Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.15 Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2017-2027
  • Figure 5.16 Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.17 France OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.18 Germany OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.19 UK OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.20 Spain OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.21 Italy OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.22 Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.23 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2017-2027
  • Figure 5.24 Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.25 China OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.26 Japan OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.27 India OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.28 Australia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.29 Thailand OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.30 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.31 RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.32 Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.33 Middle East OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.34 Africa OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.35 Other Countries OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 6.1 Porter's Five Analysis of the OTC Pharmaceutical Market, 2017
  • Figure 7.1 Bayer AG, Revenue, ($million), 2012-2016
  • Figure 7.2 Bayer AG, Product Segments Share (%), 2016
  • Figure 7.3 Bayer AG, Geographic Presence Share (%), 2016
  • Figure 7.4 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
  • Figure 7.5 GlaxoSmithKline PLC, Product Segments Share (%), 2016
  • Figure 7.6 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
  • Figure 7.7 Johnson & Johnson, Revenue, ($million), 2012-2016
  • Figure 7.8 Johnson & Johnson, Product Segments Share (%), 2016
  • Figure 7.9 Johnson & Johnson, Geographical Presence Share (%), 2016
  • Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2012-2016
  • Figure 7.11 Perrigo Company PLC, Product Segments Share (%), 2016
  • Figure 7.12 Perrigo Company PLC, Geographical Presence Share (%), 2016
  • Figure 7.13 Daiichi Sankyo Co., Ltd., Revenue, ($million), 2012-2016
  • Figure 7.14 Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2016
  • Figure 7.15 Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2016
  • Figure 7.16 Pfizer Inc., Revenue, ($million), 2012-2016
  • Figure 7.17 Pfizer Inc., Product Segments Share (%), 2016
  • Figure 7.18 Pfizer Inc., Geographical Presence Share (%), 2016
  • Figure 7.19 Procter & Gamble, Revenue, ($million), 2012-2016
  • Figure 7.20 Procter & Gamble, Product Segments Share (%), 2016
  • Figure 7.21 Procter & Gamble, Geographical Presence Share (%), 2016
  • Figure 7.22 Sanofi S.A., Revenue, ($million), 2012-2016
  • Figure 7.23 Sanofi S.A., Product Segments Share (%), 2016
  • Figure 7.24 Sanofi S.A., Geographical Presence Share (%), 2016
  • Figure 7.25 Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016
  • Figure 7.26 Reckitt Benckiser Group PLC, Product Segments Share (%), 2016
  • Figure 7.27 Cipla Inc., Revenue, ($million), 2012-2016
  • Figure 7.28 Cipla Inc., Product Segments Share (%), 2016
  • Figure 8.1 Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2017-2027
  • Figure 8.2 Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2017-2027

Companies Listed

  • Abbott Medical Optics
  • Aché Laboratórios Farmacêuticos
  • Actavis
  • Adams Respiratory Therapeutics
  • Akorn
  • Alcon
  • Allergan
  • Alliance Boots
  • Almirall
  • Amerisource Bergen
  • ANVISA
  • Apotex
  • Arena Pharmaceuticals
  • Aspen Pharmacare
  • Astellas Pharma
  • AstraZeneca
  • Aurobindo
  • B.F. Ascher & Company
  • Bausch & Lomb
  • Bayer
  • Boehringer Ingelheim
  • Boots
  • Bristol-Myers Squibb
  • Cardinal Health
  • Celesio
  • China Resources Sanjiu Pharmaceutical
  • Ciba
  • Cilag
  • Cipla
  • Costco
  • CSPC (China Shijiazhuang Pharmaceutical Group)
  • CVS
  • Daiichi Sankyo
  • Dalkhimpharm
  • Dollar General
  • Dr. Reddy's Laboratories
  • Eisai
  • Eli Lilly
  • EMS
  • Eurofarma
  • Fosun Pharma
  • Galderma
  • Genomma Lab
  • GSK
  • Guangzhou Pharmaceutical
  • Harbin Pharmaceutical Group
  • Heritage/Insight
  • Hisamitsu
  • Hypermacas
  • Im Co., Ltd.
  • Insight
  • Ipca Laboratories
  • JB Chemicals
  • Johnson & Johnson
  • Kangmei Pharmaceutical
  • Kowa
  • Kroger
  • Lion
  • LOréal
  • Lupin Limited
  • Mankind Pharma
  • McKesson
  • Mead Johnson
  • Menarini
  • Merck
  • Mylan
  • North China Pharmaceutical
  • Novartis
  • Nycomed
  • Omega Pharma
  • Otsuka
  • Paras Pharmaceuticals
  • Perrigo
  • Pfizer
  • Pharmstandard
  • Phoenix
  • Prestige Brands
  • Procter & Gamble
  • Purdue Pharma
  • Ranbaxy
  • Ratiopharm
  • Reckitt Benckiser
  • Roche
  • Rohto
  • Roxane Labs
  • Sam's Club
  • Sandoz
  • Sanofi
  • Sato
  • Sergeant
  • Shanghai Pharmaceuticals
  • Shionogi
  • Sinopharm
  • SkyePharma
  • Somaxon Pharmaceuticals
  • Sotex
  • SSL International
  • Stada
  • Sun Pharma
  • Taisho
  • Takeda
  • Teva
  • Torrent Pharmaceuticals
  • Typharm
  • UCB Pharma
  • União Química
  • Valeant
  • Velcera
  • Veropharm
  • Vivus

Organizations Mentioned in the Report

  • Association of the European Self-Medication Industry (AESGP)
  • National Pharmaceutical Pricing Authority (NPPA)
  • The Brazilian Health Surveillance Agency
  • The European Medicines Agency (EMA)
  • The Food and Drug Administration (FDA)
  • The General Directorate of Pharmaceuticals and Pharmacy (IEGM) (Turkey)
  • The Medicines and Healthcare products Regulatory Agency (MHRA)
  • The Ministry of Health, Labour and Welfare (MHLW)
  • The Pharmaceutical and Medical Devices Agency (PMDA)
Back to Top